Re: Trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Trial

in response to

Trial

Telepanel

posted on Nov 21, 2019 01:09PM

Do you have a link for the extention of the trial of Phase 2a mCRPC trial,

What phase is this new extention phase 3?? Nov 2022, I thought these cancer trials were short..... this has been 4 or 5 years and now an extention to 2020, What about a breakthough status on this trial, It seems to be working so far as all these patients are survivors and the trial is not blinded , What gives?

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply